- Home
- KF vs ANIK Comparison
KF vs ANIK Comparison
Compare KF & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KF
- ANIK
- Stock Information
- Founded
- KF 1984
- ANIK 1983
- Country
- KF United States
- ANIK United States
- Employees
- KF N/A
- ANIK N/A
- Industry
- KF Investment Managers
- ANIK Medical/Dental Instruments
- Sector
- KF Finance
- ANIK Health Care
- Exchange
- KF Nasdaq
- ANIK Nasdaq
- Market Cap
- KF 116.7M
- ANIK 133.1M
- IPO Year
- KF N/A
- ANIK 1993
- Fundamental
- Price
- KF $30.58
- ANIK $8.94
- Analyst Decision
- KF
- ANIK Buy
- Analyst Count
- KF 0
- ANIK 1
- Target Price
- KF N/A
- ANIK $15.00
- AVG Volume (30 Days)
- KF 18.4K
- ANIK 107.1K
- Earning Date
- KF 01-01-0001
- ANIK 10-30-2025
- Dividend Yield
- KF N/A
- ANIK N/A
- EPS Growth
- KF N/A
- ANIK N/A
- EPS
- KF N/A
- ANIK N/A
- Revenue
- KF N/A
- ANIK $114,548,000.00
- Revenue This Year
- KF N/A
- ANIK N/A
- Revenue Next Year
- KF N/A
- ANIK $5.34
- P/E Ratio
- KF N/A
- ANIK N/A
- Revenue Growth
- KF N/A
- ANIK 16.52
- 52 Week Low
- KF $18.30
- ANIK $7.87
- 52 Week High
- KF $25.56
- ANIK $26.00
- Technical
- Relative Strength Index (RSI)
- KF 71.98
- ANIK 49.15
- Support Level
- KF $29.45
- ANIK $8.56
- Resistance Level
- KF $30.41
- ANIK $8.89
- Average True Range (ATR)
- KF 0.36
- ANIK 0.33
- MACD
- KF 0.26
- ANIK 0.03
- Stochastic Oscillator
- KF 99.57
- ANIK 48.72
About KF Korea Fund Inc. (The) New
Korea Fund Inc is a closed-end, non-diversified management investment company. Its investment objective is to seek long-term capital appreciation through investment in securities, equity securities, of Korean companies. Its portfolio consists of the different sectors such as the auto components, banks, beverages, chemicals, aerospace and defense, insurance, machinery, and others.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.